By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 12 September 2022 iStock Alzheimer's Association recently released recommendations about using blood-based biomarkers to detect Alzheimer’s disease. The recommendations are based on research conducted by Oskar Hansson, one of MultiPark’s research group leaders. “Blood-based biomarkers for Alzheimer’s are already im

https://www.multipark.lu.se/article/multipark-researcher-behind-alzheimers-association-recommendations-about-use-alzheimers-blood-tests - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 14 September 2022 What is the best approach for treating Alzheimer's disease? Aducanumab is an amyloid beta-directed monoclonal antibody that targets the aggregated forms of amyloid beta found in the brains of people with Alzheimer's disease. In May, Dr. Niklas Mattsson-Carlgren and Dr. Ruben Smith entertained youn

https://www.multipark.lu.se/article/multipark-debate-aducanumab-yesno - 2025-07-05

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 28 September 2022 Malin Parmar. Photo: Kennet Ruona. The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lund University. Together with her research group, Malin Parmar has conducted several groundbreak

https://www.multipark.lu.se/article/malin-parmar-elected-royal-swedish-academy-sciences - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 5 October 2022 A Galectin-3-expressing microglia (green) close to Tau (red) inside patient brains. Photo: Antonio Boza Serrano. Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international collaborat

https://www.multipark.lu.se/article/biomarker-reveals-inflammatory-changes-brain-alzheimers-disease - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 7 October 2022 Jessica Giacomoni defends her thesis 14 October 2022. Cell replacement therapy has long been a hope for patients with Parkinson’s disease and efforts are on their way to use stem cell derived-dopaminergic neurons in clinical trials. On 14 October, Jessica Giacomoni defends her thesis. Her project abo

https://www.multipark.lu.se/article/turning-glia-neurons-inside-brain-phd-interview-jessica-giacomoni - 2025-07-05

Published 24 October 2022 Photo: Mostphotos. Numerous studies have suggested that eating a healthy diet may reduce a person’s risk of dementia. A new study from one of MultiPark's research groups, published in Neurology, sheds new light on the impact of having a Mediterranean diet. The Mediterranean diet includes a high intake of vegetables, legumes, fruits, fish and healthy fats such as olive oil

https://www.multipark.lu.se/article/does-mediterranean-diet-really-decrease-your-risk-dementia - 2025-07-05

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 21 October 2022 Dopamine-producing neurons that researchers from Lund University have grown in the laboratory from human embryonic stem cells (Photo: Agneta Kirby) An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. E

https://www.multipark.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 28 October 2022 Matilde Negrini defends her thesis 4 November 2022. Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and most proud moments during her Ph.D. journey. Tell us about your rese

https://www.multipark.lu.se/article/modelling-parkinsons-disease-phd-interview-matilde-negrini - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 7 November 2022 Oskar Hansson, research-leader at MultiPark, recently met with Bill Gates to discuss biomarkers for Alzheimer's disease. MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He r

https://www.multipark.lu.se/article/multipark-researcher-bill-gates-brussels - 2025-07-05

By press [at] med [dot] lu [dot] se (Medical Faculty) - published 17 November 2022 In a large international research study with 1,300 participants from, among other places, Sweden, the USA, the Netherlands and Australia, PET cameras could detect the presence of the proteins tau and amyloid in the participants' brains. iStock/baranozedem A large study led by Lund University in Sweden has shown that

https://www.multipark.lu.se/article/alzheimers-disease-can-be-diagnosed-symptoms-emerge - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 22 November 2022 Inducible viral vectors can be used to investigate the effect of human alpha synucelin on dopamine release and reuptake inside the rodent brain. Photo: Andreas Heuer's group. MultiPark’s backbone for research interactions is about to be reorganized. The 13 new special interest groups (SIGs) address

https://www.multipark.lu.se/article/brain-circuit-analysis-special-interest-group - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 23 November 2022 Roberta Battistella defends her thesis 1 December 2022. The glymphatic system clears waste products from the brain. Roberta Battistella defends her thesis about the role of this system in Parkinson’s disease on December 1. Here, she tells about her time as a Ph.D student in Iben Lundgaards research

https://www.multipark.lu.se/article/glymphatic-system-pd-phd-interview-roberta-battistella - 2025-07-05

By Press [at] med [dot] lu [dot] se (Medical Faculty) - published 29 November 2022 A microglia (Image: iStock/slevaneara) The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging. The brain's own immune cells are called microglia and are found in the central nervous system. They are big eaters that kill

https://www.multipark.lu.se/article/brains-immune-cells-can-be-triggered-slow-down-alzheimers-disease - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 2 December 2022 Magnus Lindh-Rengifo defends his thesis 16 December 2022. Walking is probably more cognitively demanding than you think. Magnus Lindh-Rengifo defends his thesis about walking aspects in neurodegenerative disorders on December 16. Read about his experiences as a Ph.D student at MultiPark. Tell us abo

https://www.multipark.lu.se/article/walking-neurodegeneration-phd-interview-magnus-lindh-rengifo - 2025-07-05

Published 3 January 2023 Foto: iStock/andresr. A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. The article was originally published as a pre

https://www.multipark.lu.se/article/optimal-blood-tests-development-new-therapies-alzheimers-disease - 2025-07-05

By helga [dot] heun [at] er [dot] lu [dot] se (Helga Heun) - published 8 December 2022 Photo: Johan Wingborg, University of Gothenburg. “Lundensare” Nobel Prize winner Arvid Carlsson (1923-2018) did not receive the prestigious Nobel Prize while living or working in Lund – but he is an alumnus! Carlsson grew up in Lund (which could clearly be heard in his Lund accent) and in 1951 he became a doctor

https://www.multipark.lu.se/article/nobel-prize-winner-arvid-carlsson-7-things-you-perhaps-did-not-know-about-him-and-his-research - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 14 December 2022 In substantia nigra, neurons expressing Calretinin seem to be more resistant to damage. Photo: Lautaro Belfiori. MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to our yo

https://www.multipark.lu.se/article/molecular-signaling-neurodegenerative-disorders-special-interest-group - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 13 January 2023 Keivan Javanshiri defends his thesis 20 January 2023. Profile photo:Tove Smeds. Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the most important findings and why sudden car

https://www.multipark.lu.se/article/cognitive-disease-beyond-brain-phd-interview-keivan-javanshiri - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 21 December 2022 We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned out to be a much appreciated event. Thank you to all participants, and thank you once again to the retreat organizing c

https://www.multipark.lu.se/article/multipark-closing-circle-2022-and-looking-forward-2023 - 2025-07-05

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 January 2023 Katrine Skovgård defends her thesis 19 January 2023. Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 19, she defends her thesis. She explains how better experimental mod

https://www.multipark.lu.se/article/why-dopamine-receptor-type-matters-phd-interview-katrine-skovgard - 2025-07-05